Joanne Killinger, PhD, DABT

 Joanne Killinger is Senior Vice President of Drug Safety and Metabolism at Wyeth Research. She is responsible for the oversight and direction of Wyeth Research’s technical and scientific activities for Drug Safety and Metabolism at four sites in the U.S. and one in Italy with a staff of approximately 490 in Drug Safety, Bioanalytical, Biotransformation, and Operations.

She held various positions in biochemical pharmacology, metabolism, pharmacokinetics, and toxicology at Ortho Pharmaceutical Corporation, Stauffer Chemical Company, Battelle and Sandoz, where she advanced to Head of Drug Safety in Basel, Switzerland. She joined Wyeth in 1996 as Assistant Vice President, Toxicology, Drug Safety and was promoted to Vice President, Drug Safety in 1999 and Senior Vice President, Drug Safety and Metabolism in 2005.

Dr. Killinger received a B.S. degree in Chemistry from Marquette University, a M.S. in Biochemistry from the University of Chicago and a Ph.D. in Biochemistry from Purdue University.

She is a Diplomate of the American Board of Toxicology and is a member of the Society of Toxicology and the PhRMA Preclinical Safety Steering Committee (DruSafe).